C1q nephropathy: A variant of focal segmental glomerulosclerosis

Glen S. Markowitz, Joshua A. Schwimmer, M. Barry Stokes, Samih Nasr, Robert L. Seigle, Anthony M. Valeri, Vivette D. D'Agati

Research output: Contribution to journalArticle

78 Scopus citations

Abstract

Background. C1q nephropathy is a poorly understood and controversial entity with distinctive immunopathologic features. In order to better define the clinical-pathologic spectrum, we report the largest single-center series. Methods. Nineteen biopsies with C1q nephropathy were identified from among 8909 native kidney biopsies received from 1994 to 2002 (0.21%). Defining criteria included (1) dominant or co-dominant immunofluorescence staining for C1q, (2) mesangial electron dense deposits, and (3) no clinical or serologic evidence of systemic lupus erythematosus (SLE). Results. The 19 patients were predominantly African American (73.7%), female (73.7%), young adults and children (range, 3 to 42 years; mean, 24.2 years). Presentation included nephrotic range proteinuria (78.9%), nephrotic syndrome (50%), renal insufficiency (27.8%), and hematuria (22.2%). No patient had hypocomplementemia or evidence of underlying autoimmune or infectious disease. Renal biopsy revealed focal segmental glomerulosclerosis (FSGS) in 17 (including six collapsing and two cellular) and minimal-change disease (MCD) in two. All biopsies displayed co-deposits of immunoglobulin G (IgG), with more variable IgM (84.2%), IgA (31.6%), and C3 (52.6%). Foot process effacement varied from 20% to 100% (mean, 51%). Twelve of 16 patients with available follow-up received immunosuppressive therapy. One patient had complete remission of proteinuria and six had partial remission. Four patients with FSGS pattern had progressive renal insufficiency, including two who reached end-stage renal disease (ESRD). Median time from biopsy to ESRD was 81 months. On multivariate analysis, the best correlate of renal insufficiency at biopsy and at follow-up was the degree of tubular atrophy and interstitial fibrosis (P = 0.0495 and 0.0341, respectively). Conclusion. C1q nephropathy falls within the clinical-pathologic spectrum of MCD/FSGS. Although further studies are needed to determine the pathomechanism of C1q deposition, we hypothesize that it may be a non-specific marker of increased mesangial trafficking in the setting of glomerular proteinuria.

Original languageEnglish (US)
Pages (from-to)1232-1240
Number of pages9
JournalKidney international
Volume64
Issue number4
DOIs
StatePublished - Oct 1 2003

Keywords

  • C1q nephropathy
  • Cellular FSGS
  • Collapsing FSGS
  • Focal segmental glomerulosclerosis
  • Minimal change disease

ASJC Scopus subject areas

  • Nephrology

Fingerprint Dive into the research topics of 'C1q nephropathy: A variant of focal segmental glomerulosclerosis'. Together they form a unique fingerprint.

  • Cite this

    Markowitz, G. S., Schwimmer, J. A., Stokes, M. B., Nasr, S., Seigle, R. L., Valeri, A. M., & D'Agati, V. D. (2003). C1q nephropathy: A variant of focal segmental glomerulosclerosis. Kidney international, 64(4), 1232-1240. https://doi.org/10.1046/j.1523-1755.2003.00218.x